Medical videos welcome to Free Medical video!
Anatomy | Animations | Cancer and mesothelioma | Clinical examination | Diseases Treatments | Herbal medicine | Histopathology | Obstetrics Gynecology | Ophthalmology | Pediatrics | Surgery | Weight loss

Most Popular
Members
Username:

Password:

 Remember me
You have 35 more plays before you must register
Register
Statistics
Total Files: 595
views Today: 940
Overall views: 2,068,331
Total Members: 9,877
Users online: 22 (0 members, 22 guests)
Top Players
kareem (1,948 plays)
Dr.Hady (1,491 plays)
hashimato (1,056 plays)
3328367 (795 plays)
ddevisrireddy (462 plays)
Search

Advertisment
 
File Info
Title: New Warnings for MRI Contrast Agents Containing Gadolinium
Description: The labeling for imaging contrast agents that contain gadolinium will soon have strong new warnings. These contrast agents are often used to improve the visibility of internal structures when patients undergo MRI procedures. Five of them have been approved in the US: Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance. The new boxed warning describes risk factors and screening procedures for a serious condition related to gadolinium exposure called nephrogenic systemic fibrosis (NSF). NSF is characterized by fibrosis of the skin, muscle and internal organs. It is debilitating and potentially fatal. The warning will state that certain patients have a higher risk of developing NSF if they are given a gadolinium-based agent. They include those with severe renal failure, whether acute or chronic, and those with acute renal failure of any severity who have hepato-renal syndrome or are in the perioperative period around liver transplantation. Clinicians should avoid using gadolinium based contrast agents with high-risk patients unless the diagnostic information is essential and cannot be obtained any other way. The new labeling will contain several other recommendations, including: • Before using these agents, all patients should be evaluated for renal failure either by obtaining a medical history or conducting laboratory tests. • When administering these products, do not exceed the dose recommended in the product labeling. And do not re-administer these agents until enough time has elapsed to ensure that the prior dose has been eliminated from the body. • After administering a gadolinium-based contrast agent, consider prompt dialysis for patients already receiving hemodialysis. It is unknown whether dialysis prevents NSF, but data indicate that it does speed up the elimination of the agent from the body
views: 688 times
Rating: 3
Rate
Tell a Friend
Free Medical video > Clinical examination > New Warnings for MRI Contrast Agents Containing Gadolinium

Share |

Comments:
Please login or register to leave a comment.
Add this file to your website:
Related Files:
Influenza Pandemics: Past and Future Influenza Pandemics: Past and Future
Science has made it possible to reconstruct the virus that caused the great i...
(Played: 424 times)
Chronic Fatigue Syndrome Chronic Fatigue Syndrome
Chronic Fatigue Syndrome
(Played: 924 times)
dialysis dialysis
dialysis
(Played: 701 times)
Weight Loss Diets: Top 3 Health, Fitness, Exercise Programs Weight Loss Diets: Top 3 Health, Fitness, Exercise Programs
HealthyNewAge.com summary of best-selling diet food, cleansing, and fat burni...
(Played: 1,164 times)
Diet to Relax the Pancreas to Cause weight loss Diet to Relax the Pancreas to Cause weight loss
A Diet program explained which retrains the pancreas to relax and decrease st...
(Played: 868 times)
Top search queries: childbirth video - free medical video - Medical videos - Gamma Knife Treatment - video of Autopsy - Catheter insertion - surgery Video -  methothelioma  - gynecology video -Autopsy videos- Medical videos - normal birth - Mesothelioma new - Autopsy video - catheter insertion - clinical examination - pediatric exam video - laparoscopic hysterectomy video - Real autopsy

All videos copyright © to their respective owner s. All rights reserved. developed by 3rbdr Medical videos